Dolutegravir Sodium Salt-d6
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for complete information.
Dolutegravir Sodium Salt-d6 Product Information
Dolutegravir Sodium Salt-d6 is listed under Stable Isotopes and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-T-97557.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
Dolutegravir Sodium Salt-d6
CAT No.
CS-T-97557
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C20H12D6F2N3NaO5
Molecular Weight
447.4
Category
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for complete information.
Description
Regulatory Description
Dolutegravir Sodium Salt-d6 is supplied with detailed characterization data compliant with regulatory guideline. Dolutegravir Sodium Salt-d6 can be used for analytical method development, method validation (AMV), Quality Control (QC), ANDA-related analytical work, and commercial pharmaceutical research applications.
Overview
"Dolutegravir Sodium Salt-d6, is the labeled analogue of Dolutegravir Sodium Salt (D528805), a second generation HIV-1 integrase strand transfer inhibitor. Dolutegravir is currently in Phase III clinical trials for the treatment of HIV infection. Dolutegravir has been shown to potently inhibit HIV replication in cells such as peripheral blood mononuclear cells (PBMCs), MT-4 cells and CIP4 cells infected with a self-inactivating PHIV lentiviral vector."
Synonyms
Dolutegravir Sodium Salt-d6
Application Notes
"Dolutegravir Sodium Salt-d6, is the labeled analogue of Dolutegravir Sodium Salt (D528805), a second generation HIV-1 integrase strand transfer inhibitor. Dolutegravir is currently in Phase III clinical trials for the treatment of HIV infection. Dolutegravir has been shown to potently inhibit HIV replication in cells such as peripheral blood mononuclear cells (PBMCs), MT-4 cells and CIP4 cells infected with a self-inactivating PHIV lentiviral vector."
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.